LONDON, December 14 /PRNewswire/ -- In response to comments made by Coroner Simon Nelson at the inquest of Linda Docherty of Bury, Greater Manchester, David Pruce, Head of Practice and Quality Improvement said:
"The Royal Pharmaceutical Society of Great Britain would like to express its concern at hearing of Mrs Docherty's death, following her addiction to Nurofen Plus."
"Pharmacists are highly skilled professionals and the public benefit from access to a wide range of medicines of this type over the counter. Medicines available over the counter can only be purchased in limited quantities."
"We would like to reassure, that when used properly, this type of medication is effective and safe to use. We would recommend that people read the instructions, do not exceed the recommended dose and that they consult their pharmacist or doctor if their symptoms persist or worsen."
"We would not at this stage support any move to reclassify this product to a prescription only medicine."
Notes to Editors
All over-the-counter (OTC) medicines, including Nurofen Plus, are regulated by the UK regulatory body, the Medicines and Healthcare products Regulatory agency (MHRA). In common with other P-licensed medicines, Nurofen Plus is only available from pharmacies and is sold under the strict supervision of qualified pharmacists who can advise on its correct use.
For media enquiries please contact: Royal Pharmaceutical Society of Great Britain's Public Relations Unit, +44(0)207-572-2653